Lonza primary immune cells and media

Friday, 11 June, 2010 | Supplied by: Lonza Australia Pty Ltd



Lonza supplies a variety of primary cells isolated from normal peripheral blood, cord blood and bone marrow along with media specifically developed for culturing primary immune cells.

Cells are available to fit specific experimental needs, with a large selection of donors and lots and multiple immune cell types are available from the same donor.

Cells are processed to ensure highly homogeneous populations with high purity (≥85%) and viabilities of 100% of the stated cell number per product label.

Primary cells include: CD41+ monocytes, CD4+ T-cells, CD19+ B-cells, dendritic cells, NK cells, mononuclear cells.

LGM-3 Lymphocyte Growth Medium-3 was developed for the growth and support of human lymphocytes and dendritic cells.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...

Diaclone research tools for cytokine storm monitoring

Diaclone provides a large panel of research tools, monoclonal antibodies and ELISA kits for...

BioLamina Biosilk biomaterial for 3D cell culture of hPSCs

BioLamina's Biosilk is a 3D cell culture biomaterial made from recombinant spider silk...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd